NEW YORK (GenomeWeb) – In a notice filed on Friday with the US Securities and Exchange Commission, SomaLogic disclosed that it has raised $16.5 million.
According to the SEC document, the sale took place on Oct. 17 with equity going to two unidentified investors.
Last month, Novartis agreed to take an equity stake in SomaLogic as part of an extension of a multi-year agreement between the two companies. It is unclear if the recent financing relates to that agreement. SomaLogic declined to comment on the offering or identify the investors.